![Glenn Whaley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn Whaley
Directeur Financier/CFO chez
IMMUNIC, INC.
Fortune : 142 883 $ au 31/05/2026
Profil
Mr. Glenn Whaley, CPA, is a Chief Financial Officer at Immunic, Inc., a Member at New Jersey Society of Certified Public Accountants and a Member at The American Institute of Certified Public Accountants.
Mr. Whaley was previously employed as a Chief Financial Officer by Pernix Therapeutics Holdings, Inc., a Vice President-Finance by Alvogen, Inc., and a Controller by ImClone Systems, Inc. He received his undergraduate degree from Rutgers Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNIC, INC. 0,07 % | 26/05/2026 | 9 551 ( 0,07 % ) | 142 883 $ | 31/05/2026 |
Postes actifs de Glenn Whaley
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNIC, INC. | Directeur Financier/CFO | 17/04/2020 |
New Jersey Society of Certified Public Accountants
 New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Corporate Officer/Principal | - |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Anciens postes connus de Glenn Whaley
| Sociétés | Poste | Fin |
|---|---|---|
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Corporate Officer/Principal | 01/03/2015 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Comptroller/Controller/Auditor | 01/05/2011 |
| PERNIX THERAPEUTICS HOLDINGS INC | Directeur Financier/CFO | - |
Formation de Glenn Whaley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
New Jersey Society of Certified Public Accountants
New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Commercial Services |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
